Data may be out of date. Our scheduled checks are behind: the last successful check of the sources finished 20 Oct 2026, 21:00 UTC (12 days ago), more than 36 hours ago. Checks normally run twice daily, so figures on this page may be out of date. See the service status.
ShortageSignal

← All medicines

Medicine · bench card

Camellia Sinensis Extract

As of 02 Nov 2026 12:58 UTC. Status is always as stated in the latest recorded notice; the sources do not publish resolution, so nothing on this page says a medicine is back — see methodology.

Latest England noticeMSN/2024/109 · issued 26 Nov 2024 (706 days ago)
Expected backmid-February 2025 as stated in the latest recorded notice stated date passed — no update recorded (620 days)window end 20 Feb 2025, derived from “mid-February 2025”
Protocolno Serious Shortage Protocol matched to this name on the NHSBSA register
ScotlandMSAN(2025)7 issued 05 Feb 2025 — NHS Scotland's own notice, matched by name; kept separate from England

Presentations, as stated in the latest recorded notice

No product lines could be read from the latest recorded notice for this medicine, so no presentation-level status is shown. The notice itself is listed in the history below.

Protocol in force

No Serious Shortage Protocol matched to this name is in force on the NHSBSA register. Matching is by name until identifier coding lands.

Named in the source as remaining available

The latest recorded notice names no alternative as remaining available.

Identifiers — Camellia Sinensis Extract

Also known as
Camellia sinensis extract 10% ointment · Catephen 10% ointment
BNF chemical
Camellia sinensis extract 1307000W0 — matched on a generic name
Class
Preparations for warts and calluses · Skin
SNOMED codes
30254811000001108, 30317911000001106
Suppliers named in the NHSBSA dataset
Kora Healthcare (from the dataset, not from the notices)

BNF chemical and SNOMED identifiers from NHSBSA Prescription Cost Analysis (Open Government Licence), matched by name (presentation name), confidence 0.90 — grouping under review where marked Release Sep 2026.

BNF SNOMED mapping, NHSBSA Copyright 2026; Prescription Cost Analysis (PCA) Monthly Administrative Data, NHSBSA Copyright 2026. This information is licenced under the terms of the Open Government Licence.

History

One supply notification on record, 26 Nov 2024. We record when a shortage is declared, not when stock returns — the source doesn't publish that. An update sharing a reference counts as one episode.

Also recorded under

Bracketed names seen in this medicine's notice titles: catephen. Grouping is by the head name in each title; brand and generic names may still sit on separate pages until identifier coding refines it — see the A–Z.

Scotland — separate record

NHS Scotland issues its own Medicine Supply Alert Notices. These match this medicine's name; they are shown beside, never added to, the England record.

Last checked
20 Oct 2026 — sources are checked twice daily by scheduled jobs, not continuously
Last source change
19 Oct 2026
Latest notice captured
12 Jul 2026
Sources
Latest notice post ↗https://cpe.org.uk/our-news/medicine-supply-notification-imiquimod-aldara-5-and-bascellex-50mg-g-cream-250mg-sachets · methodology · corrections log

Re-expressed facts with links to the source documents; roles are inferred from phrasing and flagged; fuzzy dates stay fuzzy. Not an official NHS or DHSC service and not clinical advice — in a shortage, follow the guidance issued to your pharmacy or prescriber. Absence of a record is never availability.